Approval · Notice of Compliance 16164 · 2014
PLAN B: Notice of Compliance 16164
Issued September 8, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16164
- Date
- September 8, 2014
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add the statement "#1 pharmacist and physician recommended" to the main panel label of the outer label for plan b (levonorgestrel 0.75 mg tablet)
- Therapeutic class
- Emergency contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAN B | 02241674 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB